A detailed history of Bridge City Capital, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Bridge City Capital, LLC holds 34,773 shares of AMPH stock, worth $1.29 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
34,773
Previous 34,498 0.8%
Holding current value
$1.29 Million
Previous $2.13 Million 28.46%
% of portfolio
0.57%
Previous 0.84%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$42.85 - $63.45 $11,783 - $17,448
275 Added 0.8%
34,773 $1.53 Million
Q4 2023

Feb 13, 2024

BUY
$44.49 - $62.93 $526,717 - $745,028
11,839 Added 52.25%
34,498 $2.13 Million
Q3 2023

Nov 15, 2023

SELL
$45.51 - $65.0 $7,054 - $10,075
-155 Reduced 0.68%
22,659 $1.04 Million
Q2 2023

Aug 16, 2023

BUY
$35.77 - $58.38 $816,056 - $1.33 Million
22,814 New
22,814 $1.31 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.81B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Bridge City Capital, LLC Portfolio

Follow Bridge City Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridge City Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridge City Capital, LLC with notifications on news.